|
Originally published In Press as doi:10.1074/jbc.M207407200 on September 6, 2002
J. Biol. Chem., Vol. 277, Issue 46, 44285-44291, November 15, 2002
Inhibition of Caspases Protects Cerebellar Granule Cells of the
Weaver Mouse from Apoptosis and Improves Behavioral Phenotype*
Jun
Peng ,
Zhijin
Wu§,
Yongqin
Wu ,
Mike
Hsu§,
Fang Feng
Stevenson ,
Rapee
Boonplueang§,
Suzanne K.
Roffler-Tarlov¶, and
Julie K.
Andersen §
From the Buck Institute for Age Research, Novato,
California 94945, § Program in Molecular Biology, Department
of Biological Sciences, University of Southern California, Los Angeles,
California 90089, and the ¶ Departments of Neuroscience and
Anatomy and Cell Biology, Tufts University School of Medicine,
Boston, Massachusetts 02111
Received for publication, July 23, 2002, and in revised form, September 4, 2002
 |
ABSTRACT |
The homozygous mouse mutant weaver exhibits a
massive loss of cerebellar granule neurons postnatally. The death of
these cells is associated with a single amino acid mutation in the G
protein-activated inwardly rectifying potassium channel, Girk2.
Evidence suggests that both the mutated Girk2 channel and the calcium
channel-associated N-methyl-D-aspartate
receptor play important roles in the apoptotic death of weaver
cerebellar granule cells, but the downstream events associated with
this process are unknown. In this study, we demonstrate that the
consequences of the mutation result in caspase activation. In addition,
our results show that caspase inhibition in vivo decreases
caspase activation and granule cell apoptosis and significantly improves behavioral deficits associated with the weaver's phenotype.
 |
INTRODUCTION |
The homozygous murine mutant weaver (gene symbol wv) is
characterized by ataxia, hyperactivity, and tremor (for a review, see
Ref. 1). These neurological defects are associated with the large scale
death of neurons in the cerebellum and midbrain during the first month
of postnatal development. Homozygous weaver mice exhibit death of
cerebellar granule cells (2-4), dopaminergic neurons in the substantia
nigra (5-9), Purkinje cells in the cerebellum (10-12), and neurons in
the deep cerebellar nuclei (13). The wv defect has been
identified as a point mutation in the G protein-activated inwardly
rectifying potassium channel gene, Girk2 (14). Girk channels are
activated by direct interaction with G proteins (15) and play an
important role in controlling cell membrane excitability by maintaining
the potassium equilibrium potential (16). It has been observed that the
weaver's cerebellar granule cells die by an apoptotic mechanism
(17-19). However, the precise nature of the process underlying granule
cell death is unclear.
Neuronal apoptosis often involves a family of proteases known as
caspases. Caspases are synthesized as precursors that are activated
after cleavage. Three categories of caspases have been characterized by
the specificity of their substrate cleavage site: caspases generating
mature proinflammatory cytokines (caspase-1, -4, and -5) and caspases
that traditionally act as either initiators (caspase-6, -8, and -9) or
downstream (caspase-2, -3, and -7) as executioners in the apoptotic
pathway (20, 21). During development, cell death is essential for
regulation of neuronal cell numbers as well as for protection against
the propagation of aberrant cells (22). The evidence suggests that
caspase-3 participates in neuronal cell death during development (23), after traumatic neuronal injury (24), and ischemia (25), suggesting that caspase-3 may play a critical role in the terminal stage of the
apoptotic pathway in neurons.
Death of granule cells caused by the Girk2wv mutation can be
rescued, at least for a time, both in vivo and in
vitro by elimination of the NR1 subunit of the calcium
channel-associated N-methyl-D-aspartate receptor, suggesting that this receptor may also be involved in cerebellar granule cell death (19). The studies reported here were
carried out to attempt to determine the downstream events in the death
of granule cells that carry two copies of the faulty GIRK2 channel
gene. Here we supply direct evidence for the involvement of caspases in
the death of the weaver's granule cells. Furthermore, we demonstrate
that caspase inhibition attenuates apoptosis in the weaver's granule
cells both in vitro and in vivo and also significantly attenuates behavioral deficits associated with this genetic lesion.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine
maleate (MK-801),1 QX-314,
verapamil, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) were purchased from Sigma. PCR reagents, DNA polymerase,
and the digoxigenin DNA labeling and detection kit were from
Roche Molecular Biochemicals. Rabbit polyclonal cleaved caspase-8
antibody was purchased from Smith-Kline Beecham Pharmaceuticals (King
of Prussia, PA). Rabbit polyclonal cleaved caspase-9 and rabbit
polyclonal cleaved caspase-3 antibodies were from New England Biolabs
(Beverly, MA). Z-DEVD-FMK (caspase-3 inhibitor), Z-IETD-FMK (caspase-8
inhibitor), and Z-LEHD-FMK (caspase-9 inhibitor) were purchased from BD
Biosciences (San Diego, CA). Anti-TAG-1 (4D7) antibody was from the
Developmental Hybridoma Studies Bank, University of Iowa (Iowa City,
IA). The FluorAceTM apopain assay kit and caspase substrates were
purchased from Bio-Rad.
Animals--
Weaver heterozygous mating pairs
(B6CBACa-Aw-J/A-Kcnj6wv) were purchased from
the Jackson Laboratory (Bar Harbor, ME). Generation of homozygous p35
transgenic mice has been described elsewhere (26). All animals used in
this study were generated from matings between female wv/+,
p35 +/ or wv/wv, p35 +/ mice and male wv/+, p35 +/ mice. They were maintained in the vivarium on a 12-h
(light/dark) cycle at 22 °C. All procedures were approved by the
Institute Animal Care and Use Committee at the Buck Institute.
Determination of Genotype--
Genomic tail DNA was isolated
using a kit (Qiagen). wv genotypes were determined by a PCR
protocol. This protocol uses a common reverse primer (5'-CAC GGA CTG
GAT TAA GAG GAG AAT AAT-3') in combination with a wild-type sequence
forward primer (5'-GAG ACA GAA ACC ACC ATC G-3') or a wv
sequence forward primer containing the point mutation at the 3'-end
(5'-GAG ACA GAA ACC ACC ATC A-3'). PCRs were performed in a total
volume of 25 µl and included an initial denaturation at 94 °C/5
min followed by 30 cycles each consisting of denaturation at
94 °C/30 s, annealing at 47 °C/45 s, and extension at 72 °C/60
s, and a final extension of 10 min at 72 °C. Subsequent PCR products
were subjected to electrophoresis, and the bands were visualized with
ethidium bromide. Each genomic DNA sample was tested with both pairs of
primers. Wild-type (+/+) DNA yielded an 87-bp band with wild-type
primers but not with wv primers and vice versa
for homozygous (wv/wv) DNA. Heterozygous (wv/+) DNA yielded bands with both primer pairs.
p35-positive genotypes were identified by slot blot analysis of genomic
DNA prepared from tails as described previously (26). Briefly, 5 µg
of total DNA was slotted onto positively charged membranes and
UV-cross-linked, membranes were hybridized with
digoxigenin-labeled RNA probes transcribed from p35 cDNA,
and DNA was detected by chemiluminescence.
Preparation of Cerebellar Granular Cells--
Primary cerebellar
granule cultures were isolated from 5-7-day-old pups as described
previously (27). Cells were seeded onto tissue culture plates coated
with poly-D-lysine (Sigma) and BIOCOATTM culture slides
(Becton Dickinson) in minimum essential medium (Invitrogen)
supplemented with 10% fetal calf serum, 33 mM glucose, 2 mM glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, and 20 mM supplementary KCl.
Immunocytochemistry--
Cultured cerebellar granule cells were
fixed with 4% paraformaldehyde, washed in phosphate-buffered saline,
and then incubated in phosphate-buffered saline containing 10% normal
goat serum and 0.3% Triton-X for 1 h at room temperature. The
cells were then incubated with primary antibodies (caspase-9, 1:100;
caspase-8, 1:500; caspase-3, 1:50 and TAG-1, 1:50) in blocking solution
overnight at 4 °C. The cells were washed with phosphate-buffered
saline and incubated with fluorochrome-conjugated secondary antibodies (1:200; Molecular Probes, Inc., Eugene, OR) for 1 h at room
temperature. Nuclei were counterstained with
4',6-diamidino-2-phenylindole (Vector). Control experiments were
performed in which one or the other of the primary antisera was
omitted. No staining was observed under these conditions.
Caspase Activity Assay--
The enzymatic activity of individual
caspases was determined using kits from Bio-Rad. Cells were harvested
in a buffer (10 mM HEPES, pH 7.4, 2.0 mM EDTA,
0.1% CHAPS, 5 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml pepstatin A, 10 µg/ml aprotinin, and 20 µg/ml leupeptin) and then vortexed gently and freeze-thawed four to five times. Lysates were centrifuged at 13,000 × g for 30 min at 4 °C, and the supernatants
were collected (26). Total protein extracts were measured using a
protein assay kit (Bio-Rad). Supernatant aliquots were incubated with
the synthetic substrates Ac-DEVD-AFC (for caspase-3), Ac-LETD-AFC (for
caspase-8), and Ac-LEHD-AFC (for caspase-9) for 2 h at 37 °C.
Fluorescence was measured at an excitation of 400 nm and an emission of
530 nm using a microplate spectrofluorometer. Serial dilutions of AFC
were used as standards. Substrates and inhibitors were used at dosages
reported to be optimal for specific caspase selectivity.
Cell Viability by MTT Assay--
MTT tetrazolium salt (5 mg/ml)
was added to cells grown in 96-well plates and incubated for 2 h
at 37 °C. After crystals were dissolved, absorbance at 540 nm was
measured using microplate spectrophotometry. Cell viability at days 2 and 3 was calculated as the amount of MTT dye conversion relative to
that of cells at day 1.
Histology--
Postnatal day 7 and 21 pups were anesthetized
with Nembutal and transcardially perfused with 4% paraformaldehyde in
0.1 M phosphate buffer. Brains were removed and
immersion-fixed in the same fixative overnight at room temperature.
Brains were dehydrated in graded ethanols, cleared in xylene, and
paraffin-embedded (18). 10-µm-thick serial sagittal sections were cut
and mounted on glass slides, which were dried overnight at 42 °C.
Sections were deparaffinized, rehydrated through a graded series of
ethanols, and washed in water. Terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labeled (TUNEL) staining was
performed using an in situ cell death detection kit (Roche
Molecular Biochemicals). Subsequently, the sections were counterstained
with hematoxylin. In all cases, sections examined were those near the
vermis of the cerebellum. Granule cell counts were performed as
previously described (17).
For immunohistochemical analysis of cleaved caspase-3, sections were
washed in Tris-buffered saline and blocked in Tris-buffered saline
containing 0.1% Triton X-100, 1% bovine serum albumin, and 5% normal
goat serum for 30 min at room temperature. Sections were incubated
with a 1:1000 dilution of primary antibody overnight at 4 °C and
washed in Tris-buffered saline. Sections were incubated with a 1:1000
dilution of Cy3-conjugated secondary antibody (Jackson ImmunoResearch).
Behavioral Testing--
Spontaneous locomotor activity, rest
time, and climbing ability were measured in an automated Tru Scan®
photobeam activity system (Coulbourn Instruments, Allentown, PA) under
illumination. Animals were habituated to the apparatus for 15 min prior
to running the experiment. Behavioral data were collected in the
apparatus over a 10-min period and then analyzed using Tru Scan 99 software (Coulbourn Instruments, Allentown, PA). Depth of holes for
climbing experiments was 23 mm deep at a diameter of 22 mm. Rest times were considered any period of 2 s or longer of inactivity.
Statistical Analysis--
Results shown represent the mean ± S.E. for the number (n) of independent experiments
performed. Statistical analysis of the data was performed using an
analysis of variance software package (Statview).
 |
RESULTS |
Involvement of Caspases in Weaver Cerebellar Granule Cell
Death--
Apoptosis is initiated by activation of specific proteases
of the caspase family (21). To determine whether the major initiator caspase-8 and/or -9 or the executioner caspase, caspase-3, are involved
in weaver granule cell death and to delineate their sequence of
activation, proteolytic activities associated with these caspases were
measured by immunocytochemistry and enzymatic assays. Cerebellar granule cells were purified from postnatal day 5 (P5) homozygous (wv/wv) and wild-type (+/+) mice and cultured for
different times before assessing the processing of cleaved caspase-9,
-8, and -3 via immunocytochemistry. Caspase-9 induction as monitored by immunofluorescence in wv/wv granule cells
occurred first at 18 h, followed by caspase-3 induction at 24 h, which in turn preceded caspase-8 induction at 36 h. In cultures
from wv/wv mice, activated caspase-8 and -9 were
demonstrated to be primarily in the cytoplasm, whereas caspase-3 showed
both nuclear and cytoplasmic localization (Fig.
1A). Negligible
caspase-positive activity was noted in +/+ cultures.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
Caspase involvement in
wv/wv granule cell death. P5
cerebellar granule cells were isolated from +/+ and
wv/wv mice. A, caspase-9, -8, and -3 are activated in +/+ and wv/wv cerebellar
granule cells. Cells were fixed and immunostained for active caspase-9,
-8, and -3 using antibodies specific for these proteins
(red). 4',6-Diamidino-2-phenylindole staining was used to
identify cell nuclei (blue). Original magnification, ×40.
B, time course of caspase-9, -8, and -3 activities.
Cytosolic protein extracts were from +/+ and
wv/wv cerebellar granule cells grown in the
absence or presence of 25 µM caspase-9 inhibitor, 25 µM caspase-8 inhibitor, and 25 µM caspase-3
inhibitor as described under "Experimental Procedures"
(n = 4). *, p < 0.01; **,
p < 0.001, significantly different from +/+. #,
p < 0.01, significantly different from
wv/wv.
|
|
To assess temporal activation of the individual caspases, we examined
the activities of each using specific fluorometric caspase substrates.
Wild-type cerebellar granule cells exhibited minimal activity of
caspase-9, -3, and -8, whereas weaver cerebellar granule cells
exhibited a significant 2-6-fold increase in levels of activated caspase-9, -3, and -8 at 18, 24, and 36 h in vitro,
respectively (Fig. 1B). A selective caspase-9 inhibitor,
Z-LEHD-FMK, significantly attenuated the increases in caspase-9, -3, and -8 activities, whereas neither the caspase-8 inhibitor (Z-IETD-FMK)
nor the caspase-3 inhibitor (Z-DEVD-FMK) inhibited caspase-9 activity
(Fig. 1B). These data corroborate our immunocytochemical
data demonstrating the activation of these caspases in the weaver mouse
and furthermore indicate that caspase-9 is activated upstream of both
caspase-3 and -8.
Rescue of Weaver Cerebellar Granule Cells by Caspase
Inhibition--
Granule neurons purified from P5-7 cerebella were
cultured, and cell viability was measured by the MTT assay. As shown in Fig. 2A, there was a 25-50%
greater incidence of death among wv/wv cells
compared with +/+ neurons at 2 and 3 days in vitro. Granule neurons isolated from wv/wv cerebella were
cultured in the presence of 20 µM MK-801, 20 µM verapamil, and 100 µM QX-314. Our data corroborate earlier findings (28) demonstrating that these cationic channel blockers markedly enhanced wv/wv granule cell
viability (Fig. 2A), supporting the hypothesis that the
mutant channel is nonselective, fluxing Na+. Our data show
that wv/wv granule cell viability was equally protected by either a general or a caspase-9-specific caspase inhibitor. This suggests that caspase-9 activation is involved in the
granule cell death associated with the wv/wv
mutation (Fig. 2A).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Rescue of weaver granule cells.
A, cell viability in cerebellar granule cells in
vitro as measured by MTT assay in +/+, wv/wv
cells grown in the absence or presence of 20 µM MK-801,
20 µM verapamil, 100 µM QX-314,
wv/wv cells expressing p35, or
wv/wv cells grown in the presence of 25 µM caspase-9 inhibitor, n = 4. *,
p < 0.001, significantly different from +/+. #,
p < 0.01, significantly different from
wv/wv. B, time course of caspase-9,
caspase-3, and caspase-8 activities in presence of either cationic
channel blockers or p35 (n = 4). *, p < 0.01; **, p < 0.001, significantly different from
+/+. #, p < 0.01, significantly different from
wv/wv.
|
|
Baculoviral p35 is a general caspase inhibitory protein similar to
CrmA that acts to suppress host defense mechanisms that otherwise would eliminate virus-infected bacteria by apoptosis (29, 30). p35 is known to bind and to inhibit multiple vertebrate (26)
and invertebrate caspases (31). It has been shown to protect against
apoptosis induced by a variety of stimuli in a variety of different
model systems (32). To assess the effect of the presence of
GIRK2wv on caspase activation levels, time courses of
activation of caspase-9, -3, and -8 in wv/wv
cells in the absence or presence of p35 expression via crossing weaver mice with a transgenic mouse model previously generated in our laboratory (26) or pharmacological cationic channel blockers were
performed. As shown in Fig. 2B, the intracellular activity levels of caspase-9, -3, and -8 were significantly increased in wv/wv granule neurons up to 48 h in
vitro as compared with +/+ neurons. p35 expression had a profound
effect on caspase activities, resulting in a significant decrease in
caspase activation in granule cells from wv/wv
with p35 mice (Fig. 2B). Significantly, the channel blockers
MK-801, verapamil, and QX-314 largely prevented caspase-9, -3, and -8 activation in wv/wv granule neurons (Fig.
2B).
Developmental differentiation of cerebellar granule neurons can be
monitored via the transient expression of TAG-1, a glycoprotein localized in the plasma membrane whose expression in cerebellar granule
cells is restricted to the period of axonal elongation during the first
two postnatal weeks in mice (28, 33). To test whether rescued
wv/wv granule cells are able to proceed with differentiation, cultured cells were assayed for TAG-1, which is
expressed by postmitotic +/+ granule cells during the period of
axonogenesis (34) but not by weaver granule cells, which normally fail
to differentiate (28). Surviving untreated weaver granule cells were
TAG-1-negative as expected but did express the antigen if treated with
the cationic channel inhibitor QX-314 as previously shown (28). As
illustrated in Fig. 3,
wv/wv, p35 granule cells also express TAG-1,
demonstrating that caspase inhibition allows
wv/wv granule cell differentiation to proceed
through axonogenesis at least in vitro.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Axonal glycoprotein TAG-1 expression in
cerebellar granule cells in vitro. Cerebellar
granule cells were purified from P5 mice and cultured for 2 days before
immunocytochemistry was performed to assess presence of TAG-1
expression (red). Nuclei were identified by counterstaining
with 4',6-diamidino-2-phenylindole (blue). A,
+/+. B, wv/wv. C,
wv/wv with p35. D,
wv/wv cells grown in the presence of 100 µM QX-314. Original magnification, ×40.
|
|
Apoptosis during Postnatal Cerebellar Development in Vivo Rescued
by Caspase Inhibition--
To assess whether p35 expression attenuates
apoptosis during cerebellar development in vivo, we used
in situ end labeling to identify apoptotic cells (Fig.
4, A and B). The
morphological and spatial characteristics of cell death were examined
in the cerebella of P7 and P21 +/+ mice and wv/wv
mice in the presence or absence of p35 expression. As previously shown
(18), in situ end-labeling reactions carried out on sagittal
sections from the vermis demonstrated substantial levels of apoptotic
cell death in the cerebella of P7 wv/wv mice (Fig.
4A). TUNEL-labeled cells detected in the P7 cerebella
were mostly found along the inner margin of the external germinal layer
(EGL), where postmitotic, premigratory granule cells are positioned in
+/+ mice at these ages, but a few were located in the internal granular
layer (IGL). The numbers of TUNEL-labeled cells in the EGL appeared to
be greatly reduced in wv/wv mice expressing p35.
Few apoptotic cells were present in the EGL of the +/+ mice either in
the absence or presence of p35 (Fig. 4A). Again, as
previously demonstrated (18), by P21 the weaver cerebellum was found to
display significant EGL cell loss with continued presence of
TUNEL-labeled cells in the few remaining cells present and little
normal migration into the IGL (Fig. 4B). In contrast,
wv/wv mice expressing the p35 transgene appeared
to display a decrease in TUNEL-labeled EGL cells compared with weaver
alone as well as an increase in the number of cells in the IGL.

View larger version (102K):
[in this window]
[in a new window]
|
Fig. 4.
Morphological apoptotic cell death in
developing +/+ and wv/wv cerebella
in vivo in the absence or presence of p35
expression. Shown are photomicrographs of TUNEL cells (TUNEL cells
are shown in red and indicated by white
arrowheads in the +/+ panel) in sagittal sections
from cerebella of P7 (A) and P21 (B) mice.
Original magnification, ×20. The sections were counterstained with
hematoxylin (purple). C, TUNEL cell counts
performed in sagittal sections from wv/wv mice without or
with p35 cerebella at P7 and P21 (n = 3). *,
p < 0.01, significantly different from
wv/wv. D, the number of granule cells
in EGL of P7 cerebella (n = 3). *, p < 0.001, significantly different from +/+. #, p < 0.05, significantly different from wv/wv. E,
the number of granule cells of P21 cerebella (n = 3).
#, p < 0.01, significantly different from
wv/wv.
|
|
To more carefully assess cellular apoptosis in the cerebellum in the
absence or presence of p35 expression, the numbers of TUNEL cells in
the EGL near the vermis were quantitated in wv/wv mice in the absence or presence of p35 expression. A significant reduction in the numbers of TUNEL cells in the EGL of
wv/wv mice expressing p35 compared with control
wv/wv mice at both P7 and P21 was observed (Fig.
4C). Furthermore, there was a significant increase in the
total number of EGL granule cells in P7 wv/wv mice in the presence versus absence of p35 expression,
whereas no significant difference in EGL granule cell numbers was
observed between P7 +/+ mice in the absence or presence of p35
expression (Fig. 4D). No significant difference in IGL or
total granule cell numbers was noted between +/+ mice in the absence or
presence of the transgene by P21 (data not shown). However, as shown in Fig. 4E, an increase in the total number of granule cells
including IGL was observed in P21 wv/wv mice
expressing p35 compared with wv/wv mice.
To assess caspase activation in vivo in
wv/wv mice with or without p35 expression, we
used immunohistochemical localization with a cleaved caspase-3-specific
antibody (Fig. 5). Whereas intense staining for cleaved caspase-3 was observed throughout the cerebellar EGL of wv/wv mice not expressing p35 (Fig.
5A), in the cerebellum from P7 wv/wv
animals expressing the transgene, markedly fewer cleaved
caspase-3-positive cells were found compared with
wv/wv only littermates (Fig. 5B).
Wild-type cerebella showed negligible caspase-3 immunostaining (data
not shown).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Caspase inhibitor attenuates caspase-3
activation in vivo. Photomicrographs of cleaved
caspase-3 immunolabeled cells (red) in sagittal sections
from EGL of cerebella from P7 wv/wv mice in the
absence (A) or presence (B) of p35 expression
staining seen throughout EGL is much reduced by p35. Individual cells
and clusters are shown (arrowheads). Scale
bar, 100 µm.
|
|
Behavioral Deficits in Weaver Mice Attenuated by Caspase
Inhibition--
The weaver behavioral phenotype is characterized by
gait instability, outward splaying of hind limbs, tremor, curled
posture, and severe ataxia (35). Presumably, the massive loss of
granule cells accounts for at least some of the weaver's motor
deficiencies. In the present experiments, the performance of P21 +/+,
wv/+, and wv/wv mice both expressing
p35 and not expressing p35 was compared on a battery of behavioral
tests in an open field environment. The tests included spontaneous
locomotion, mean velocity, rest time, and climbing ability. We observed
no significant difference in these four parameters between +/+ and
wv/+ mice, whether or not they expressed p35, consistent
with past reports. In contrast, wv/wv mice had
decreased locomotor behavior (i.e. movement was slower, and
they moved shorter distances per move) and increased rest time compared
with +/+ or wv/+ over a 10-min trial period. During the rest
periods, defined as lack of detectable activity by the apparatus for a
period of 2 s or longer, we observed that wv/wv mice remained fairly stationary. In
contrast, the +/+ mice were engaged in grooming behavior during the
rest period. In addition, the wv/wv mice were
~10 times slower to crawl onto a platform from a hole 23 mm deep × 22 mm in diameter at the bottom of the apparatus. The behavioral
deficits in the wv/wv were partially rescued in
the presence of p35 expression (Fig. 6).
These data point to an improvement in coordination in the weaver mice
that express the p35 transgene.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Behavioral differences in weaver mice with or
without p35 expression. A, average distance per move.
B, mean velocity. C, rest time. D,
total time spent in hole. All experiments were performed during a
10-min trial period after 15 min of habituation to the apparatus. Rest
times were considered to be any cessation in detectable activity for a
period of 2 s or longer. For hole climbing experiments, animals
were placed in 23-cm holes of 22-mm diameter, and the time to climb out
was assessed. Sample sizes were 5 (+/+, p35 / ), 9 (+/+, p35 ±), 8 (+/+, p35 +/+), 7 (wv/+, p35 / ), 16 (wv/+,
p35 ±), 13 (wv/+, p35 +/+), 4 (wv/wv,
p35 / ), 10 (wv/wv, p35 +/ ), and 9 (wv/wv, p35 +/+). *, p < 0.05;
**, p < 0.01, significantly different from wild-type;
#, p < 0.05; ##, p < 0.01, significantly different from p35 / .
|
|
 |
DISCUSSION |
Cell death in the weaver mouse has up until now been primarily
described morphologically (3, 4, 18) with limited biochemical evidence
suggesting by what mechanism this occurs (36, 37). Although a few
studies have implicated apoptosis in weaver cerebellar granule cell
death (18, 36), the exact cause of apoptotic cell death remains
unknown. Apoptosis has been shown to occur by both
caspase-dependent and -independent means. We show here that
the mutation that leads to the weaver phenotype, Girk2wv, elicits apoptosis in granule cells by caspase activation. Furthermore, results from our pharmacological and immunocytochemical experiments establish that caspase-9 is the apical upstream caspase involved in
cerebellar granule cell death in the weaver mouse. Caspase-9 is
normally involved in propagating intracellular apoptotic stimuli. Caspase-9 can in turn cleave and activate downstream executioner caspases such as caspase-3. This leads to cleavage of additional cellular substrates, resulting in morphological changes associated with
apoptosis including DNA fragmentation and cytoskeletal disruption (38,
39). Recent evidence from cell-free and in vitro expression systems have suggested that in addition to being a final effector in
neuronal apoptosis, caspase-3 is also capable of eliciting cleavage and
activation of the initiator caspase, caspase-8 (40, 41). Although
caspase-8 activation is generally thought to occur upstream of
caspase-9, we have recently demonstrated that caspase-8 activation in
dopaminergic neurons in the MPTP mouse model of Parkinson's disease
occurs downstream of activation of both caspase-9 and caspase-3 (42).
Neuronal cell death in the weaver's cerebellum may involve a similar
pathway of caspase activation. This is to our knowledge the first
identification of a molecular cell death pathway acting downstream of
the altered ion channel function responsible for cell loss in the
weaver mutant.
Intriguingly, caspase-3 was found in our studies to be expressed
throughout the EGL in P7 weaver mice including in the external-most subdivision where the proliferating granule cells reside. The GIRK2
channel protein has also been found to be expressed in mitotic cells of
the EGL (28, 43-45). In contrast, TUNEL staining (a marker of DNA
fragmentation, a late stage in the apoptotic process) is found
primarily in the postmitotic cells at the internal edge of the EGL
(Fig. 4) (18). Taken together, these data suggest that caspase-induced
apoptosis triggered by the GIRK2 mutation is initiated during the
mitotic phase in cerebellar granule neurons, although cell death
becomes morphologically evident only later at the time of postmitotic differentiation.
These studies also show that neuronal expression of the baculoviral
protein p35 significantly attenuates caspase activation both in
vitro and in vivo, resulting in a reduction in numbers of apoptotic cerebellar granule cells in wv/wv
mice and an increase in IGL cell numbers (Fig. 4), although not all
granule cells containing the GIRK2 mutation undergo cell death but
primarily those at the vermis (13, 19). This suggests decreased
apoptosis and increased migration of cells from the EGL to the IGL in
wv/wv mice in the presence of the p35 transgene.
In previous studies of this line of p35 transgene, we observed the
highest level of expression of the transgene in the cerebellum. In
addition, neuronal expression of p35 in these animals was found to
significantly lower caspase activation induced by either staurosporine
or lowered extracellular K+ levels in primary cerebellar
granule cells cultured in vitro (26).
Our present data demonstrate that caspase inhibition via p35 allows
weaver cerebellar granule cell differentiation to proceed in
vitro as exemplified by their expression of the late neuronal differentiation marker TAG-1. Weaver cerebellar granule cells without
p35 fail to extend axonal processes and to express TAG-1 (28, 46). This
suggests that caspase inhibition and subsequent attenuation of granule
cell death allows some cells to differentiate beyond the stage of
migration and axonogenesis, which could explain the observed
improvement in coordination in these animals in vivo. These
data are further corroborated by in vivo increases in the number of cells in the P21 IGL of the p35-expressing weaver mice, suggesting that the presence of the transgene results in a delay in
apoptotic cell death. Delayed cell death could allow some cells to
undergo normal migration from the EGL to the IGL and to functionally differentiate. The presence of TUNEL cells in the IGL further suggests
that apoptosis may be delayed in these cells. Whereas p35 expression
does not fully reverse cerebellar granule cell loss in the weaver, the
rescue is sufficient to allow diminished cell loss and a partial
attenuation of behavioral effects in the presence of the transgene.
The results of this study are consistent with the view that
Na+ influx is responsible for subsequent caspase activation
and apoptotic cell death in weaver cerebellar granule cells. Previous
electrophysiological experiments using heterologous systems have
suggested that GIRK2wv results in Na+ influx
through a nonselective channel (28, 43, 47, 48). Electrophysiological
studies of the weaver's granule neurons have proven more
controversial. Some groups have reported that the mutated channel
appears to be nonselective, leading to increased Na+
permeability (28, 43, 47, 48), whereas others have reported that the
mutation results in loss in channel function (49, 50). Our in
vitro data agree with earlier reports that neurons can be rescued
from apoptotic cell death by the addition of cationic channel blockers
(e.g. MK-801, verapamil, and QX-314). We found here that
these same channel blockers also prevent caspase-9, -8, and -3 activation. This suggests that cationic influx is required for caspase
activation, triggering this otherwise irreversible program of cell
death (Fig. 2).
In conclusion, we have demonstrated that the mutant channel in granule
cells results in subsequent caspase activation in vitro and
in vivo. The activation of caspases is initiated prior to differentiation in mitotic cells in the EGL. Furthermore, based on
immunocytochemistry and enzymatic assays, caspase-9 is the apical
caspase involved in the subsequent neuronal cell death process, which
also involves caspase-3 and -8 (Fig. 7).
Caspase inhibition by p35 decreases caspase activation and allows
neuronal differentiation to proceed in the weaver's granule cells,
resulting in an attenuation in cerebellar granule apoptosis both
in vitro and in vivo and at least some degree of
normal migration and differentiation in vivo. Cerebellar
granule cell viability in association with an improvement in weaver
behavior has been previously reported by another group (19).
Interestingly, in this case granule cells were reversed when NR1
N-methyl-D-aspartate subunits were
knocked out in weaver NR1 double mutants. The differences in behavioral deficits were described, but quantitative data were not presented. We
also found that the partial block or delay in cell death has functional
consequences. Homozygous weaver mice that also carried p35 were far
better coordinated and less ataxic that homozygous weavers without p35.
p35 reversed the motor deficits seen in homozygous weavers in all four
tests of motor behavior administered. This was particularly striking in
the hole climbing task. Weaver mice without p35 were dramatically
impaired in terms of their ability to climb out of a 23-cm hole.
However, in the presence of the p35 transgene, this was completely
reversed to wild-type levels.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Proposed mechanism of weaver cerebellar
granule apoptotic cell death. The Girk2 channel mutation
results in Na+ and/or Ca2+ influx. The increase
in intracellular cation levels leads to the activation of caspase-9 and
the subsequent activation of procaspase-3 and -8, resulting in neuronal
cell apoptosis.
|
|
Understanding the molecular events underlying neuronal cell loss in the
weaver's mouse and how to reverse them may not only aid us in
understanding this specific process but also may lend insight into
treatment of related human disorders in which neurodegeneration plays a
major role.
 |
ACKNOWLEDGEMENT |
We thank Dr. Joan C. Schein for helpful
suggestions on the PCR.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants AG12141, NS21461, and AG51980 (to J. K. A.) and NS20181 (to S. K. R.-T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Buck Institute for
Age Research, 8001 Redwood Blvd., Novato, CA 94945. Tel.: 415-209-2070; Fax: 415-209-2231; E-mail: jandersen@buckinstitute.org.
Published, JBC Papers in Press, September 6, 2002, DOI 10.1074/jbc.M207407200
 |
ABBREVIATIONS |
The abbreviations used are:
MK-801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
maleate;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid;
TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeled;
EGL, external germinal layer;
IGL, internal granular layer;
Z-, benzyloxycarbonyl-;
P5, P7, and P21, postnatal day 5, 7, and 21, respectively;
FMK, fluoromethylketone;
AFC, 7-amino-4-trifluoromethyl
coumarin.
 |
REFERENCES |
| 1.
|
Caviness, V. S., Jr.,
and Rakic, P.
(1978)
Annu. Rev. Neurosci.
1,
297-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Rezai, Z.,
and Yoon, C. H.
(1972)
Dev. Biol.
29,
17-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Rakic, P.,
and Sidman, R. L.
(1973)
J. Comp. Neurol.
152,
103-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Rakic, P.,
and Sidman, R. L.
(1973)
J. Comp. Neurol.
152,
133-161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Schmidt, M. J.,
Sawyer, B. D.,
Perry, K. W.,
Fuller, R. W.,
Foreman, M. M.,
and Ghetti, B.
(1982)
J. Neurosci.
2,
376-380[Abstract]
|
| 6.
|
Roffler-Tarlov, S.,
and Graybiel, A. M.
(1984)
Nature
307,
62-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Triarhou, L. C.,
Norton, J.,
and Ghetti, B.
(1988)
Exp. Brain Res.
70,
256-265[Medline]
[Order article via Infotrieve]
|
| 8.
|
Graybiel, A. M.,
Ohta, K.,
and Roffler-Tarlov, S.
(1990)
J. Neurosci.
10,
720-733[Abstract]
|
| 9.
|
Roffler-Tarlov, S.,
Martin, B.,
Graybiel, A. M.,
and Kauer, J. S.
(1996)
J. Neurosci.
16,
1819-1826[Abstract/Free Full Text]
|
| 10.
|
Blatt, G. J.,
and Eisenman, L. M.
(1985)
J. Comp. Neurol.
232,
117-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Herrup, K.,
and Trenkner, E.
(1987)
Neuroscience
23,
871-885[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Smeyne, R. J.,
and Goldowitz, D.
(1990)
Brain Res. Dev. Brain Res.
52,
211-218[Medline]
[Order article via Infotrieve]
|
| 13.
|
Maricich, S. M.,
Soha, J.,
Trenkner, E.,
and Herrup, K.
(1997)
J. Neurosci.
17,
3675-3683[Abstract/Free Full Text]
|
| 14.
|
Patil, N.,
Cox, D. R.,
Bhat, D.,
Faham, M.,
Myers, R. M.,
and Peterson, A. S.
(1995)
Nat. Genet.
11,
126-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Clapham, D. E.
(1994)
Annu. Rev. Neurosci.
17,
441-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Ehrengruber, M. U.,
Doupnik, C. A., Xu, Y.,
Garvey, J.,
Jasek, M. C.,
Lester, H. A.,
and Davidson, N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7070-7075[Abstract/Free Full Text]
|
| 17.
|
Smeyne, R. J.,
and Goldowitz, D.
(1989)
J. Neurosci.
9,
1608-1620[Abstract]
|
| 18.
|
Harrison, S. M.,
and Roffler-Tarlov, S. K.
(1998)
Dev. Biol.
195,
174-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Jensen, P.,
Surmeier, D. J.,
and Goldowitz, D.
(1999)
J. Neurosci.
19,
7991-7998[Abstract/Free Full Text]
|
| 20.
|
Salvesen, G. S.,
and Dixit, V. M.
(1997)
Cell
91,
443-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Cryns, V.,
and Yuan, J.
(1998)
Genes Dev.
12,
1551-1570[Free Full Text]
|
| 22.
|
Henderson, C. E.
(1996)
Neuron
17,
579-585[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kuida, K.,
Haydar, T. F.,
Kuan, C. Y., Gu, Y.,
Taya, C.,
Karasuyama, H., Su, M. S.,
Rakic, P.,
and Flavell, R. A.
(1998)
Cell
94,
325-337[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Yakovlev, A. G.,
Knoblach, S. M.,
Fan, L.,
Fox, G. B.,
Goodnight, R.,
and Faden, A. I.
(1997)
J. Neurosci.
17,
7415-7424[Abstract/Free Full Text]
|
| 25.
|
Namura, S.,
Zhu, J.,
Fink, K.,
Endres, M.,
Srinivasan, A.,
Tomaselli, K. J.,
Yuan, J.,
and Moskowitz, M. A.
(1998)
J. Neurosci.
18,
3659-3668[Abstract/Free Full Text]
|
| 26.
|
Viswanath, V., Wu, Z.,
Fonck, C.,
Wei, Q.,
Boonplueang, R.,
and Andersen, J. K.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2270-2275[Abstract/Free Full Text]
|
| 27.
|
Hatten, M. E.
(1985)
J. Cell Biol.
100,
384-396[Abstract/Free Full Text]
|
| 28.
|
Kofuji, P.,
Hofer, M.,
Millen, K. J.,
Millonig, J. H.,
Davidson, N.,
Lester, H. A.,
and Hatten, M. E.
(1996)
Neuron
16,
941-952[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Clem, R. J.,
Fechheimer, M.,
and Miller, L. K.
(1991)
Science
254,
1388-1390[Abstract/Free Full Text]
|
| 30.
|
Ray, C. A.,
Black, R. A.,
Kronheim, S. R.,
Greenstreet, T. A.,
Sleath, P. R.,
Salvesen, G. S.,
and Pickup, D. J.
(1992)
Cell
69,
597-604[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Sugimoto, A.,
Friesen, P. D.,
and Rothman, J. H.
(1994)
EMBO J.
13,
2023-2028[Medline]
[Order article via Infotrieve]
|
| 32.
|
Miller, L. K.
(1999)
Trends Cell Biol.
9,
323-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bailly, Y.,
Kyriakopoulou, K.,
Delhaye-Bouchaud, N.,
Mariani, J.,
and Karagogeos, D.
(1996)
J. Comp. Neurol.
369,
150-161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Yamamoto, M.,
Hassinger, L.,
and Crandall, J. E.
(1990)
J. Neurocytol.
19,
619-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Sidman, R. L.,
Green, M. C.,
and Appel, S. H.
(1965)
Catalog of the Neurological Mutants of the Mouse
, pp. 66-67, Harvard University Press, Cambridge, MA
|
| 36.
|
Wullner, U.,
Weller, M.,
Schulz, J. B.,
Krajewski, S.,
Reed, J. C.,
and Klockgether, T.
(1998)
Acta Neuropathol.
96,
233-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Migheli, A.,
Piva, R.,
Casolino, S.,
Atzori, C.,
Dlouhy, S. R.,
and Ghetti, B.
(1999)
Am. J. Pathol.
155,
365-373[Abstract/Free Full Text]
|
| 38.
|
Nunez, G.,
Benedict, M. A., Hu, Y.,
and Inohara, N.
(1998)
Oncogene
17,
3237-3245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Stennicke, H. R.,
and Salvesen, G. S.
(2000)
Biochim. Biophys. Acta
1477,
299-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Wolf, B. B,
and Green, D. R.
(1999)
J. Biol. Chem.
274,
20049-20052[Free Full Text]
|
| 41.
|
Tang, D.,
Lahti, J. M.,
and Kidd, V. J.
(2000)
J. Biol. Chem.
275,
9303-9307[Abstract/Free Full Text]
|
| 42.
|
Viswanath, V., Wu, Y.,
Boonplueang, R.,
Chen, S.,
Stevenson, F. F.,
Yantiri, F.,
Yang, L.,
Beal, M. F.,
and Andersen, J. K.
(2001)
J. Neurosci.
21,
9519-9528[Abstract/Free Full Text]
|
| 43.
|
Slesinger, P. A.,
Patil, N.,
Liao, Y. J.,
Jan, Y. N.,
Jan, L. Y.,
and Cox, D. R.
(1996)
Neuron
16,
321-331[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Lauritzen, I., De,
Weille, J.,
Adelbrecht, C.,
Lesage, F.,
Murer, G.,
Raisman-Vozari, R.,
and Lazdunski, M.
(1997)
Brain Res.
753,
8-17[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Schein, J. C.,
Hunter, D. D.,
and Roffler-Tarlov, S.
(1998)
Dev. Biol.
204,
432-450[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Gao, W. Q.,
Liu, X. L.,
and Hatten, M. E.
(1992)
Cell
68,
841-854[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Navarro, B.,
Kennedy, M. E.,
Velimirovic, B.,
Bhat, D.,
Peterson, A. S.,
and Clapham, D. E.
(1996)
Science
272,
1950-1953[Abstract]
|
| 48.
|
Silverman, S. K.,
Kofuji, P.,
Dougherty, D. A.,
Davidson, N.,
and Lester, H. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15429-15434[Abstract/Free Full Text]
|
| 49.
|
Surmeier, D. J.,
Mermelstein, P. G.,
and Goldowitz, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11191-11195[Abstract/Free Full Text]
|
| 50.
|
Rossi, P., De,
Filippi, G.,
Armano, S.,
Taglietti, V.,
and D'Angelo, E.
(1998)
J. Neurosci.
18,
3537-3547[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Peng, L. Peng, F. F. Stevenson, S. R. Doctrow, and J. K. Andersen
Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration
J. Neurosci.,
June 27, 2007;
27(26):
6914 - 6922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Peng, L. Xie, F. F. Stevenson, S. Melov, D. A. Di Monte, and J. K. Andersen
Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration.
J. Neurosci.,
November 8, 2006;
26(45):
11644 - 11651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Peng, F. F. Stevenson, S. R. Doctrow, and J. K. Andersen
Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra: IMPLICATIONS FOR PARKINSON DISEASE
J. Biol. Chem.,
August 12, 2005;
280(32):
29194 - 29198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Peng, X. O. Mao, F. F. Stevenson, M. Hsu, and J. K. Andersen
The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway
J. Biol. Chem.,
July 30, 2004;
279(31):
32626 - 32632.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|